menu
    • menu

    Company profile for GeneTx Biotherapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    GeneTx Biotherapeutics was setup as a subsidiary of the Foundation for Angelman Syndrome Therapeutics for the development and commercialization of an investigational antisense drug, GTX-102, for the treatment of Angelman syndrome (AS). Angelman syndrome (AS) is a rare genetic disorder that affects approximately one in 15,000 live births. AS is caused by a loss of function of the maternally inherited UBE3A gene. Symptoms of AS ...
    GeneTx Biotherapeutics was setup as a subsidiary of the Foundation for Angelman Syndrome Therapeutics for the development and commercialization of an investigational antisense drug, GTX-102, for the treatment of Angelman syndrome (AS). Angelman syndrome (AS) is a rare genetic disorder that affects approximately one in 15,000 live births. AS is caused by a loss of function of the maternally inherited UBE3A gene. Symptoms of AS include developmental delay, impaired motor function, loss of speech, and epilepsy. GeneTx Biotherapeutics’ GTX-102 is designed to compensate for the deficiencies that result from the underlying genetic causes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GeneTx BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5020 Clark Road, #240 Sarasota, FL 34233
    Telephone
    Telephone
    +1 (630) 639-7271
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.genetxbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ultragenyx and GeneTx Provide Program Update on GTX-102 for Angelman Syndrome
    Ultragenyx and GeneTx Provide Program Update on GTX-102 for Angelman Syndrome

    18 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/18/2481331/20739/en/Ultragenyx-and-GeneTx-Provide-Program-Update-on-GTX-102-for-Angelman-Syndrome-Including-Promising-Interim-Data-from-Phase-1-2-Study.html

    GLOBENEWSWIRE
    18 Jul 2022
    Share Share
    Ultragenyx granted go-ahead to up doses for Angelman therapy
    Ultragenyx granted go-ahead to up doses for Angelman therapy

    06 Jan 2022

    // STREETINSIDER

    https://www.streetinsider.com/Corporate+News/Ultragenyx+Pharma+%28RARE%29+and+GeneTx+Issues+Update+on+Phase+12+Clinical+Study+of+GTX-102/19422427.html

    STREETINSIDER
    06 Jan 2022
    Share Share
    FDA Lifts Clinical Hold from Ultragenyx-GeneTx's Angelman syndrome candidate
    FDA Lifts Clinical Hold from Ultragenyx-GeneTx's Angelman syndrome candidate

    28 Sep 2021

    // N. DeFeudis ENDPTS

    https://endpts.com/after-pumping-the-brakes-on-their-angelman-syndrome-study-ultragenyx-and-genetx-are-back-in-the-race/

    N. DeFeudis ENDPTS
    28 Sep 2021
    Share Share
    GeneTx and Ultragenyx get UK approval for Angelman syndrome trial
    GeneTx and Ultragenyx get UK approval for Angelman syndrome trial

    11 Jun 2021

    // CLINICAL TRAILS ARENA

    https://www.clinicaltrialsarena.com/news/genetx-ultragenyx-angelman-syndrome-trial/

    CLINICAL TRAILS ARENA
    11 Jun 2021
    Share Share
    GeneTx and Ultragenyx Receive Clearance from Health Canada Clinical of GTX-102
    GeneTx and Ultragenyx Receive Clearance from Health Canada Clinical of GTX-102

    18 May 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/05/19/2232478/20739/en/GeneTx-and-Ultragenyx-Receive-Clearance-from-Health-Canada-to-Begin-Clinical-Study-of-GTX-102-in-Canada-for-the-Treatment-of-Angelman-Syndrome.html

    GLOBENEWSWIRE
    18 May 2021
    Share Share
    Gene therapy for autism-linked condition weakened legs, robbing two people
    Gene therapy for autism-linked condition weakened legs, robbing two people

    05 Nov 2020

    // Giorgia Guglielmi, Spectrum SCIENCEMAG

    https://www.sciencemag.org/news/2020/11/gene-therapy-autism-linked-condition-weakened-legs-robbing-two-people-ability-walk

    Giorgia Guglielmi, Spectrum SCIENCEMAG
    05 Nov 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search